[All-trans retinoic acid and arsenic trioxide: their molecular mechanisms of action and updated clinical progress in APL therapy].
作者信息
Shinagawa Katsuji
出版信息
Rinsho Ketsueki. 2011 Jul;52(7):469-83.
PMID:21821978
Abstract
摘要
相似文献
1
2
The acute promyelocytic leukaemia success story: curing leukaemia through targeted therapies.急性早幼粒细胞白血病的成功故事：通过靶向治疗治愈白血病。
J Intern Med. 2014 Jul;276(1):61-70. doi: 10.1111/joim.12208.
3
[Treatment for acute promyelocytic leukemia].[急性早幼粒细胞白血病的治疗]
Rinsho Ketsueki. 2014 Oct;55(10):1817-26.
4
Successful post-remission therapy with a combination of all-trans retinoic acid and arsenic trioxide in an elderly Japanese patient newly diagnosed with acute promyelocytic leukemia.全反式维甲酸与三氧化二砷联合用于一名新诊断的老年日本急性早幼粒细胞白血病患者的缓解后治疗取得成功。
Int J Hematol. 2010 Jan;91(1):152-3. doi: 10.1007/s12185-009-0470-7. Epub 2009 Dec 25.
5
Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: a TRAnsition to targeted therapies.表观遗传学在急性早幼粒细胞白血病发病机制及治疗反应中的作用：向靶向治疗的转变
Br J Cancer. 2015 Feb 3;112(3):413-8. doi: 10.1038/bjc.2014.374. Epub 2014 Sep 23.
6
Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia.急性早幼粒细胞白血病对三氧化二砷和维甲酸治疗的耐药性。
Ann Hematol. 2017 Apr;96(4):707-708. doi: 10.1007/s00277-017-2923-z. Epub 2017 Feb 2.
7
Contemporary treatment of APL.急性早幼粒细胞白血病的当代治疗
Curr Hematol Malig Rep. 2014 Jun;9(2):193-201. doi: 10.1007/s11899-014-0205-6.
8
Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia.适应性免疫与脂质体全反式维甲酸（ATRA）协同作用，促进急性早幼粒细胞白血病小鼠的长期分子缓解。
Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9468-73. doi: 10.1073/pnas.132657799. Epub 2002 Jun 20.
9
Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia.儿童恶性肿瘤中的分化诱导剂：全反式维甲酸和砷剂在急性早幼粒细胞白血病中的应用
Curr Oncol Rep. 2000 Nov;2(6):519-23. doi: 10.1007/s11912-000-0105-x.
10
Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.在急性早幼粒细胞白血病（APL）的治疗中，全反式维甲酸和三氧化二砷是否已取代全反式维甲酸和蒽环类药物成为标准治疗方案。
Best Pract Res Clin Haematol. 2014 Mar;27(1):39-52. doi: 10.1016/j.beha.2014.04.003. Epub 2014 Apr 12.
Zotero 插件